Navigation Links
ASGCT Announces Plan to Educate the Public on Gene Editing in a Newly Released White Paper
Date:11/22/2016

On Nov. 21, 2016, the American Society of Gene & Cell Therapy (ASGCT) released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017.

Researchers, physicians, and patients believe gene editing can greatly improve the outlook for currently incurable genetic diseases, such as muscular dystrophy, sickle cell disease, cystic fibrosis, and hemophilia, among many others. Genetic diseases are caused by mutations in genes and currently impact more than 30 million Americans, 2/3 of whom are children. Gene editing seeks to correct or change genes only in cells in which the alteration is expected to have a therapeutic benefit to patients.

The drug treatments currently approved for genetic diseases only manage symptoms, they do not address the underlying cause of the disease. “The successful development of gene editing applications could shift a lifetime of symptom management towards tomorrow’s ideal of a one-time curative treatment for patients,” said Dr. Cynthia Dunbar, ASGCT’s President, noting that the process is monitored closely by global regulators including the FDA and their European counterparts.

A cohort of ASGCT member scientists traveled to Washington on Nov. 18 to present the Society’s educational materials to relevant congressional committees and administrative agencies, including the U.S. Senate Health, Education, Labor, and Pension (HELP) Committee and the White House Office of Science and Technology. The goal of these meetings was to educate policy-makers on the fundamentals of gene editing.

The NAS consensus report, which is slated to be released in early 2017, is expected to address ethical, legal, and social implications of gene editing. ASGCT believes its November white paper will be a useful tool to assist advocacy groups, lawmakers, and the news media to better interpret the 2017 NAS consensus report.

The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. ASGCT's mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease. For more information, visit http://www.asgct.org.

Read the full story at http://www.prweb.com/releases/2016/11/prweb13874042.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Diet Doc’s Prescription Hormone Diets & Weight Loss Plans Announces New Clean Eating Diet Plans to Slim the Waistline While Reducing the Risk for Colorectal Cancer
2. EmpowHER’s Michelle King Robson Announces Launch of HER Radio – Exploring all things Woman
3. Innovations with Ed Begley, Jr. Announces New Episode Airing November 14, 2013 via Discovery Channel
4. T.E.N. Announces Winners of the ISE® North America Awards
5. AED.com Announces That All Employees Now Carry a Personal AED
6. Phoenix Treatment Center Announces New Video Explaining Its Services for Drug, Alcohol Addiction
7. Innovaacom Announces November Launch of New Hospital-Based Physician Training Program
8. Coffee Beanery Announces Grand Opening of New Store in Memorial City Mall
9. Wichita Drug Rehab Announces New Video Explaining Services Offered Through Drug Addiction Treatment Centers
10. PriceAngels.com Announces Its Cheapest Android Tablet Collection
11. iFitDress.com Announces The Release Of Light Green Wedding Dresses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... May 21, 2020 , ... A new report from ... over 90 companies involved in the point of care test industry. Given the ... testing, COVID-19 has made point-of-care more important than in the past, according to the ...
(Date:5/16/2020)... ... May 15, 2020 , ... ... new collaboration with the Open Source Medical Supplies (OSMS). The organization will obtain ... efforts to reduce the spread of COVID-19. , Created as a response to ...
(Date:5/15/2020)... NEW YORK (PRWEB) , ... May 15, 2020 , ... ... will come together for Home is Where the Heart Is, a benefit to support ... a rare genetic disorder that causes tumors to grow on nerves throughout the body ...
(Date:5/14/2020)... (PRWEB) , ... May 14, 2020 , ... SGF , a premier fertility and ... of fertility procedures and treatment in the Tampa Bay region. , “While this pandemic has ... ways our team members and patients have risen to the occasion. Through the work of ...
(Date:5/14/2020)... STEVENSVILLE, Md. (PRWEB) , ... May 13, 2020 , ... ... with the Centers for Medicare and Medicaid Services (CMS), DLA awarded Federal Resources a ... million gowns, and 64.4 million pairs of gloves to ensure the safety and well-being ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... ... May 21, 2020 , ... Sindledecker ... The offices had been closed due to the coronavirus pandemic and the practice ... field. The office has remained open only for emergency needs and the staff, ...
(Date:5/21/2020)... MURRIETA, Ga. (PRWEB) , ... May 21, 2020 , ... ... the RESI (Redefining Early Stage Investments) Conference to offer startup companies a ... 9 and 10. , The RESI conference series was created by LSN to bring ...
(Date:5/21/2020)... , ... May 21, 2020 , ... Labyrinthe Labs has ... formula called Lefa . A soothing cream designed for fast-action relief of joint ... plant phytocannabinoids proven to soothe and support tired joints and muscles. , According ...
Breaking Medicine Technology: